Samlyn Capital, LLC Insmed Inc Transaction History

Samlyn Capital, LLC

$6.21 Billion
Q3 2024

A detailed history of Samlyn Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Samlyn Capital, LLC holds 211,498 shares of INSM stock, worth $14 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

211,498

Previous 359,254 41.13%

Holding current value

$14 Million

Previous $24.1 Million 35.86%

% of portfolio

0.25%

Previous 0.43%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $9.16 Million - $11.7 Million	-147,756 Reduced 41.13%	211,498 $15.4 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $5.02 Million - $15.9 Million	-228,380 Reduced 38.86%	359,254 $24.1 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $18 Million - $20.9 Million	-699,234 Reduced 54.34%	587,634 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $2.21 Million - $2.99 Million	-94,189 Reduced 6.82%	1,286,868 $39.9 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $11.8 Million - $16.1 Million	-596,233 Reduced 30.15%	1,381,057 $34.9 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $4,373 - $5,612	-266 Reduced 0.01%	1,977,290 $41.7 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $638,383 - $853,141	39,261 Added 2.03%	1,977,556 $33.7 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $12.8 Million - $17.4 Million	751,428 Added 63.31%	1,938,295 $38.7 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $1.42 Million - $1.92 Million	68,194 Added 6.1%	1,186,867 $25.6 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $886,137 - $1.33 Million	51,912 Added 4.87%	1,118,673 $22.1 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $4.91 Million - $6.76 Million	-240,231 Reduced 18.38%	1,066,761 $25.1 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $1.13 Million - $1.46 Million	43,589 Added 3.45%	1,306,992 $35.6 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $1.18 Million - $1.55 Million	52,689 Added 4.35%	1,263,403 $34.8 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $15.8 Million - $23.5 Million	652,579 Added 116.92%	1,210,714 $34.5 Million
Q1 2021 May 17, 2021	SELL	$32.28 - $44.3 $4.27 Million - $5.86 Million	-132,276 Reduced 19.16%	558,135 $19 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $21.7 Million - $28 Million	690,411 New	690,411 $23 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account

Samlyn Capital, LLC Insmed Inc Transaction History